Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Diagnostic testing for hypopituitarism

Peter J Snyder, MD
Section Editor
David S Cooper, MD
Deputy Editor
Kathryn A Martin, MD


The diagnosis of hypopituitarism, defined as deficient secretion of one or more pituitary hormones because of pituitary or hypothalamic disease, is made by documenting subnormal secretion of these pituitary hormones in defined circumstances. Each pituitary hormone must be tested separately, since there is a variable pattern of hormone deficiency among patients with hypopituitarism. Diagnostic testing for hypopituitarism will be discussed here. The causes, clinical manifestations, and treatment of hypopituitarism are reviewed separately. (see "Causes of hypopituitarism" and "Clinical manifestations of hypopituitarism" and "Treatment of hypopituitarism")


The impetus to measure pituitary hormones is the suspicion that the secretion of one or more may be subnormal [1]. This suspicion can be based upon the knowledge that the patient has either a lesion known to cause hypopituitarism or a symptom known to be caused by hypopituitarism. The knowledge that the patient has a lesion that can cause hypopituitarism, eg, a sellar mass, is by itself sufficient reason to test for hypopituitarism because some patients with hypopituitarism have no symptoms.


For normal health, the basal secretion of corticotropin (ACTH) must be sufficient to maintain the serum cortisol concentration within the normal range. For survival, it must increase to raise serum cortisol concentrations in times of physical stress.

Basal ACTH secretion — To test basal ACTH secretion, serum cortisol should be measured at 8 to 9 AM, and the results should be interpreted as follows:

A serum cortisol value of ≤3 mcg/dL (83 nmol/L; normal range 5 to 25 mcg/dL [138 to 690 nmol/L]), confirmed by a second determination, is strong evidence of cortisol deficiency, which in a patient with a disorder known to cause hypopituitarism is usually the result of that disorder. Such a finding in the absence of any known cause of hypopituitarism mandates measurement of serum ACTH. A serum ACTH value not higher than normal is inappropriately low and establishes the diagnosis of secondary adrenal deficiency (ie, pituitary or hypothalamic disease). A value higher than normal documents primary adrenal insufficiency (ie, adrenal disease). (See "Diagnosis of adrenal insufficiency in adults".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Jul 18, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101:3888.
  2. Spark RF. Simplified assessment of pituitary-adrenal reserve. Measurement of serum 11-deoxycortisol and cortisol after metyrapone. Ann Intern Med 1971; 75:717.
  3. Jubiz W, Meikle AW, West CD, Tyler FH. Single-dose metyrapone test. Arch Intern Med 1970; 125:472.
  4. Landon J, Greenwood FC, Stamp TC, Wynn V. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest 1966; 45:437.
  5. Streeten DH, Anderson GH Jr, Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab 1996; 81:285.
  6. Soule SG, Fahie-Wilson M, Tomlinson S. Failure of the short ACTH test to unequivocally diagnose long-standing symptomatic secondary hypoadrenalism. Clin Endocrinol (Oxf) 1996; 44:137.
  7. Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991; 72:773.
  8. Mayenknecht J, Diederich S, Bähr V, et al. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998; 83:1558.
  9. Soule S, Van Zyl Smit C, Parolis G, et al. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism. Clin Endocrinol (Oxf) 2000; 53:221.
  10. Nye EJ, Grice JE, Hockings GI, et al. Adrenocorticotropin stimulation tests in patients with hypothalamic-pituitary disease: low dose, standard high dose and 8-h infusion tests. Clin Endocrinol (Oxf) 2001; 55:625.
  11. Suliman AM, Smith TP, Labib M, et al. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency. Clin Endocrinol (Oxf) 2002; 56:533.
  12. Ospina NS, Al Nofal A, Bancos I, et al. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2016; 101:427.
  13. Hartman ML, Crowe BJ, Biller BM, et al. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002; 87:477.
  14. Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002; 87:2067.